PMID- 35745755 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220716 IS - 1999-4923 (Print) IS - 1999-4923 (Electronic) IS - 1999-4923 (Linking) VI - 14 IP - 6 DP - 2022 May 31 TI - Polyphenols-Rich Fraction from Annona muricata Linn. Leaves Attenuates Oxidative and Inflammatory Responses in Neutrophils, Macrophages, and Experimental Lung Injury. LID - 10.3390/pharmaceutics14061182 [doi] LID - 1182 AB - Annona muricata Linn. is a common plant found in the warmest regions of South and Central America and its use in traditional medicine has been reported for the treatment of various illnesses. In the current study, we investigate the antioxidant and anti-inflammatory activities of crude extract and fractions from A. muricata L. leaves in isolated murine phagocytic immune cells as well as experimental LPS-induced acute lung injury (ALI). In a luminol-dependent chemiluminescence assay, we showed that ethyl acetate (EtOAc.f) and n-butanol (BuOH.f) fractions-both rich in polyphenols-reduced the generation of reactive oxygen species (ROS) by neutrophils stimulated with opsonized zymosan; similar results were found in culture of bone marrow-derived macrophages (BMDMs). By evaluating anti-inflammatory activity in BMDMs, EtOAc.f and BuOH.f reduced secretion of IL-6 and expression of the co-stimulatory molecule CD40. Furthermore, in LPS-induced ALI, oral administration of EtOAc.f reduced myeloperoxidase (MPO) activity in lung tissue. In addition, on a mechanism dependent on glutathione levels, the oxidative damage was also attenuated. These findings revealed direct antioxidant and anti-inflammatory activities of polyphenols-rich fractions of A. muricata L. leaves on neutrophils and macrophages. Moreover, the reduced oxidative damage and levels of inflammatory markers in experimental ALI suggest that these fractions might be explored for the development of new therapies for inflammatory conditions. FAU - Saraiva, Andre Lopes AU - Saraiva AL AD - Institute of Biotechnology, Federal University of Uberlandia, Rua Acre s/n, Bloco 2E, Uberlandia 38400-902, MG, Brazil. FAU - Justino, Allisson Benatti AU - Justino AB AD - Institute of Biotechnology, Federal University of Uberlandia, Rua Acre s/n, Bloco 2E, Uberlandia 38400-902, MG, Brazil. FAU - Franco, Rodrigo Rodrigues AU - Franco RR AUID- ORCID: 0000-0002-9138-311X AD - Institute of Biotechnology, Federal University of Uberlandia, Rua Acre s/n, Bloco 2E, Uberlandia 38400-902, MG, Brazil. FAU - Silva, Heitor Cappato Guerra AU - Silva HCG AD - Institute of Biotechnology, Federal University of Uberlandia, Rua Acre s/n, Bloco 2E, Uberlandia 38400-902, MG, Brazil. FAU - Arruda, Felipe Dos Santos AU - Arruda FDS AUID- ORCID: 0000-0002-6775-390X AD - Department of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Rua 235, Setor Leste Universitario, Goiania 74605-050, GO, Brazil. FAU - Klein, Sandra Gabriela AU - Klein SG AD - Rodent Vivarium Network (REBIR), Dean of Research and Graduate Studies, Federal University of Uberlandia, Rua Ceara s/n, Bloco 4U, Uberlandia 38405-315, MG, Brazil. FAU - Celes, Mara Rubia Nunes AU - Celes MRN AUID- ORCID: 0000-0002-4733-007X AD - Department of Bioscience and Technology, Institute of Tropical Pathology and Public Health, Federal University of Goias, Rua 235, Setor Leste Universitario, Goiania 74605-050, GO, Brazil. FAU - Goulart, Luiz Ricardo AU - Goulart LR FAU - Espindola, Foued Salmen AU - Espindola FS AUID- ORCID: 0000-0002-6937-1411 AD - Institute of Biotechnology, Federal University of Uberlandia, Rua Acre s/n, Bloco 2E, Uberlandia 38400-902, MG, Brazil. LA - eng GR - 465669/ 2014-0/Institutos Nacionais de Ciencia e Tecnologia/ GR - APQ-01856-14/Fundacao de Amparo a Pesquisa do Estado de Minas Gerais/ PT - Journal Article DEP - 20220531 PL - Switzerland TA - Pharmaceutics JT - Pharmaceutics JID - 101534003 PMC - PMC9228609 OTO - NOTNLM OT - Annonaceae OT - acute lung injury OT - macrophages OT - natural products OT - neutrophils OT - reactive oxygen species COIS- The authors declare that there are no conflict of interest. EDAT- 2022/06/25 06:00 MHDA- 2022/06/25 06:01 PMCR- 2022/05/31 CRDT- 2022/06/24 01:37 PHST- 2022/03/08 00:00 [received] PHST- 2022/05/23 00:00 [revised] PHST- 2022/05/26 00:00 [accepted] PHST- 2022/06/24 01:37 [entrez] PHST- 2022/06/25 06:00 [pubmed] PHST- 2022/06/25 06:01 [medline] PHST- 2022/05/31 00:00 [pmc-release] AID - pharmaceutics14061182 [pii] AID - pharmaceutics-14-01182 [pii] AID - 10.3390/pharmaceutics14061182 [doi] PST - epublish SO - Pharmaceutics. 2022 May 31;14(6):1182. doi: 10.3390/pharmaceutics14061182.